Detalhe da pesquisa
1.
MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
Gynecol Oncol
; 120(2): 247-55, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21093894
2.
The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
Gynecol Oncol
; 123(1): 129-37, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21782227
3.
Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
Gynecol Oncol
; 117(1): 88-95, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20056268
4.
New frontiers for ovarian cancer risk evaluation: proteomics and contrast-enhanced ultrasound.
AJR Am J Roentgenol
; 194(2): 349-54, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20093595
5.
Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles.
AJR Am J Roentgenol
; 194(2): 343-8, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20093594
6.
VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.
Gynecol Oncol
; 115(3): 414-23, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19765808
7.
LPA receptor 2 mediates LPA-induced endometrial cancer invasion.
Gynecol Oncol
; 112(1): 215-23, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19019417
8.
Roles of LPA in ovarian cancer development and progression.
Future Oncol
; 5(10): 1659-73, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20001802
9.
Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography.
J Ultrasound Med
; 28(10): 1273-80, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19778872
10.
Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
Cancer Res
; 67(5): 2030-9, 2007 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17332331
11.
Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.
Mol Cancer Res
; 5(2): 121-31, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17314270
12.
S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
Gynecol Oncol
; 110(2): 237-45, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18513786
13.
Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner.
Gynecol Oncol
; 108(2): 361-9, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18073130
14.
Torg syndrome is caused by inactivating mutations in MMP2 and is allelic to NAO and Winchester syndrome.
J Bone Miner Res
; 22(2): 329-33, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17059372
15.
Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
Mol Cancer Res
; 4(11): 831-41, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17114341
16.
A robust biomarker discovery pipeline for high-performance mass spectrometry data.
J Bioinform Comput Biol
; 5(5): 1023-45, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17933009
17.
S1P and LPA have an attachment-dependent regulatory effect on invasion of epithelial ovarian cancer cells.
Gynecol Oncol
; 107(2): 298-309, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17716713
18.
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.
J Clin Oncol
; 23(15): 3614-21, 2005 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15908672
19.
Selective induction of cyclooxygenase-2 plays a role in lysophosphatidic acid regulated Fas ligand cell surface presentation.
FEBS Lett
; 580(2): 443-9, 2006 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-16376882
20.
Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
Cancer Lett
; 236(2): 292-301, 2006 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-16019136